Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,772 results for "Product Liability Law & Strategy"...

Federal Jurisdiction Reform
February 27, 2013
Whether a case is litigated in federal court rather than state court can have a huge impact on both litigation costs and the end result. Some proposals for federal jurisdiction reform.
Drug & Device News
February 27, 2013
News of importance for you and your practice.
Pension Funding: A Program to Maximize Pension Growth and Limit Volatility
February 25, 2013
With proper planning, a pension can meet regulations, be funded to the acceptable green zone levels (80%) and reduce the annual net periodic pension funding requirement.
Evolving Court Views on Requests for ISP User Identities
January 31, 2013
When copyright suits are instituted over file-sharing infringements that take place over the Internet, the copyright owner may not know much about who the infringers are. Even in the best case, a plaintiff is unlikely to start with much more than an Internet Protocol (IP) address ' the number that identifies a computer or group of computers that may have been used to download or share all or part of an infringing file.
Guide to Privacy Law Compliance
January 31, 2013
When you set out to design and implement a data privacy compliance program for an e-commerce company or other organization, you face a number of threshold decisions and preparatory tasks, including putting a person or team in charge of data privacy law compliance.
FTC Updates COPPA
January 31, 2013
The FTC has made revisions that update the Children's Online Privacy Protection Act (COPPA) for the era of mobile technology, social media and online data collection ' creating new liability for the operators of websites and services that are directed to children under the age of 13.
Movers & Shakers
January 30, 2013
Who's doing what; who's going where.
Disparagement By Implication: Does an Insurer Owe a Duty to Defend?
January 30, 2013
Two conflicting California appellate court decisions issued this year highlight the difficulty of determining when an insurer owes a duty to defend disparagement by implication claims. This article discusses the two divergent California decisions, as well as fact patterns that courts have generally agreed are (and are not) implied disparagement claims triggering an insurer's duty to defend
Case Notes
January 30, 2013
Analysis of a recent key ruling.
Practice Tip: Protecting Your Verdict
January 30, 2013
The purpose of this article is to help the practitioner preserve his or her favorable trial verdict against allegations of juror impropriety. To that end, Part One herein identifies some of the most common juror-related pitfalls, and provides strategies for countering the allegations and tactics that could give rise to a new trial.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›